Lessons from natural molecules
The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
A Molecular View of Microbial Diversity and the Biosphere
Pace, N. R. (1997) · Science · doi:10.1126/science.276.5313.734 · Cited by 3,188
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082 · cited 1×
“For example, between 1981 and 2002, 5p of the 1,031 new chemical entities approved as drugs by the US Food and Drug Administration (FDA) were natural products, and another 23p were natural-product-derived molecule”
BackgroundTarget-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery
Schreiber, S. L. (2000) · Science · doi:10.1126/science.287.5460.1964 · Cited by 2,568
Engineering a mevalonate pathway in Escherichia coli for production of terpenoids
Martin, V. J. J., Pitera, D. J., Withers, S. T., Newman, J. D., & Keasling, J. D. (2003) · Nature Biotechnology · doi:10.1038/nbt833 · Cited by 1,725
VÉZINA, C., KUDELSKI, A., & SEHGAL, S. N. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.721 · Cited by 1,687
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583
A Planning Strategy for Diversity‐Oriented Synthesis
Burke, M. D., & Schreiber, S. L. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200300626 · Cited by 1,493
The influence of natural products upon drug discovery (Antiquity to late 1999)
Newman, D. J., Cragg, G. M., & Snader, K. M. (2000) · Natural Product Reports · doi:10.1039/a902202c · Cited by 1,293 · cited 1×
“Natural products have been invaluable as tools for deciphering the logic of biosynthesis and as platforms for developing front-line drug”
MethodIsolating "Uncultivable" Microorganisms in Pure Culture in a Simulated Natural Environment
Kaeberlein, T., Lewis, K., & Epstein, S. S. (2002) · Science · doi:10.1126/science.1070633 · Cited by 1,237
Cited by
Natural products in drug discovery: advances and opportunities
Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., Taskforce, T. I. N. P. S., Orhan, I. E., Banach, M., Rollinger, J. M., Barreca, D., Weckwerth, W., Bauer, R., et al. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00114-z · Cited by 5,392
Natural products: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.008 · Cited by 2,906
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
MassBank: a public repository for sharing mass spectral data for life sciences
Horai, H., Arita, M., Kanaya, S., Nihei, Y., Ikeda, T., Suwa, K., Ojima, Y., Tanaka, K., Tanaka, S., Aoshima, K., et al. (2010) · Journal of Mass Spectrometry · doi:10.1002/jms.1777 · Cited by 2,529
Drug discovery from medicinal plants
Balunas, M. J., & Kinghorn, A. D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.012 · Cited by 1,810
Anti-infective potential of natural products: How to develop a stronger in vitro ‘proof-of-concept’
Cos, P., Vlietinck, A. J., Berghe, D. V., & Maes, L. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.04.003 · Cited by 1,603
Impact of Natural Products on Developing New Anti-Cancer Agents
Cragg, G. M., Grothaus, P. G., & Newman, D. J. (2009) · Chemical Reviews · doi:10.1021/cr900019j · Cited by 1,302
A status review on the medicinal properties of essential oils
Raut, J. S., & Karuppayil, S. M. (2014) · Industrial Crops and Products · doi:10.1016/j.indcrop.2014.05.055 · Cited by 1,266
Thoughts and facts about antibiotics: Where we are now and where we are heading
Bérdy, J. (2012) · The Journal of Antibiotics · doi:10.1038/ja.2012.27 · Cited by 1,165
Multidrug Tolerance of Biofilms and Persister Cells
Lewis, K. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75418-3_6 · Cited by 804
Developing a new resource for drug discovery: marine actinomycete bacteria
Fenical, W., & Jensen, P. R. (2006) · Nature Chemical Biology · doi:10.1038/nchembio841 · Cited by 786
Combined Effects on Selectivity in Fe-Catalyzed Methylene Oxidation
Chen, M. S., & White, M. C. (2010) · Science · doi:10.1126/science.1183602 · Cited by 765
Natural products as leads to anticancer drugs
Gordaliza, M. (2007) · Clinical and Translational Oncology · doi:10.1007/s12094-007-0138-9 · Cited by 701
New antibiotics from bacterial natural products
Clardy, J., Fischbach, M. A., & Walsh, C. T. (2006) · Nature Biotechnology · doi:10.1038/nbt1266 · Cited by 615
Self-citationResistance Development to Bacteriophages Occurring during Bacteriophage Therapy
Oechslin, F. (2018) · Viruses · doi:10.3390/v10070351 · Cited by 594
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
Wang, L., Waltenberger, B., Pferschy-Wenzig, E.-M., Blunder, M., Liu, X., Malainer, C., Blazevic, T., Schwaiger, S., Rollinger, J. M., Heiss, E. H., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.018 · Cited by 594
Triggering cryptic natural product biosynthesis in microorganisms
Scherlach, K., & Hertweck, C. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b821578b · Cited by 574
Koch, M. A., Schuffenhauer, A., Scheck, M., Wetzel, S., Casaulta, M., Odermatt, A., Ertl, P., & Waldmann, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503647102 · Cited by 544
Udwary, D. W., Zeigler, L., Asolkar, R. N., Singan, V., Lapidus, A., Fenical, W., Jensen, P. R., & Moore, B. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700962104 · Cited by 536
New aspects of natural products in drug discovery
Lam, K. S. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.04.001 · Cited by 531
Venoms as a platform for human drugs: translating toxins into therapeutics
King, G. F. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.621940 · Cited by 516
Kibble, M., Saarinen, N., Tang, J., Wennerberg, K., Mäkelä, S., & Aittokallio, T. (2015) · Natural Product Reports · doi:10.1039/c5np00005j · Cited by 489
Plant-derived compounds in clinical trials
Saklani, A., & Kutty, S. K. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.010 · Cited by 477
Terpenoids: Opportunities for Biosynthesis of Natural Product Drugs Using Engineered Microorganisms
Ajikumar, P. K., Tyo, K., Carlsen, S., Mucha, O., Phon, T. H., & Stephanopoulos, G. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700151b · Cited by 447
Use of Natural Products as Chemical Library for Drug Discovery and Network Pharmacology
Gu, J., Gui, Y., Chen, L., Yuan, G., Lu, H.-Z., & Xu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062839 · Cited by 410
The natural history of antibiotics
Clardy, J., Fischbach, M. A., & Currie, C. R. (2009) · Current Biology · doi:10.1016/j.cub.2009.04.001 · Cited by 402
Self-citationCharting, Navigating, and Populating Natural Product Chemical Space for Drug Discovery
Lachance, H., Wetzel, S., Kumar, K., & Waldmann, H. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300288g · Cited by 398
Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase
Keller, T. L., Zocco, D., Sundrud, M. S., Hendrick, M., Edenius, M., Yum, J., Kim, Y.-J., Lee, H.-K., Cortese, J. F., Wirth, D. F., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.790 · Cited by 394
New approaches to molecular cancer therapeutics
Collins, I., & Workman, P. (2006) · Nature Chemical Biology · doi:10.1038/nchembio840 · Cited by 391
Small Molecule Natural Products in the Discovery of Therapeutic Agents: The Synthesis Connection
Wilson, R. M., & Danishefsky, S. J. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo0610053 · Cited by 387
Twenty-five years of research on medicinal plants in Latin America
Calixto, J. B. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.06.004 · Cited by 383
Natural products for human health: an historical overview of the drug discovery approaches
Bernardini, S., Tiezzi, A., Laghezza Masci, V., & Ovidi, E. (2018) · Natural Product Research · doi:10.1080/14786419.2017.1356838 · Cited by 355
Spring, D. R. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b310752n · Cited by 347
Tubulin-Interactive Natural Products as Anticancer Agents
Kingston, D. G. I. (2009) · Journal of Natural Products · doi:10.1021/np800568j · Cited by 328
Natural Products in Caries Research: Current (Limited) Knowledge, Challenges and Future Perspective
Jeon, J.-G., Rosalen, P. L., Falsetta, M. L., & Koo, H. (2011) · Caries Research · doi:10.1159/000327250 · Cited by 311
The evolution of gene collectives: How natural selection drives chemical innovation
Fischbach, M. A., Walsh, C. T., & Clardy, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709132105 · Cited by 309
Self-citationSmall molecules: the missing link in the central dogma
Schreiber, S. L. (2005) · Nature Chemical Biology · doi:10.1038/nchembio0705-64 · Cited by 306
Wolfender, J.-L., Nuzillard, J.-M., van der Hooft, J. J. J., Renault, J.-H., & Bertrand, S. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05112 · Cited by 305
Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment
Garcia-Oliveira, P., Otero, P., Pereira, A. G., Chamorro, F., Carpena, M., Echave, J., Fraga-Corral, M., Simal-Gandara, J., & Prieto, M. A. (2021) · Pharmaceuticals · doi:10.3390/ph14020157 · Cited by 303
Enantiomeric Natural Products: Occurrence and Biogenesis
Finefield, J. M., Sherman, D. H., Kreitman, M., & Williams, R. M. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107204 · Cited by 299
Identification of Direct Protein Targets of Small Molecules
Lomenick, B., Olsen, R. W., & Huang, J. (2011) · ACS Chemical Biology · doi:10.1021/cb100294v · Cited by 299
A practical view of ‘druggability’
Keller, T. H., Pichota, A., & Yin, Z. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.06.014 · Cited by 295
Diversity-oriented synthesis; a spectrum of approaches and results
Spandl, R. J., Bender, A., & Spring, D. R. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b719372f · Cited by 281
Exogenous influences on plant secondary metabolite levels
Pavarini, D. P., Pavarini, S. P., Niehues, M., & Lopes, N. P. (2012) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2012.07.002 · Cited by 273
Genomes to natural products PRediction Informatics for Secondary Metabolomes (PRISM)
Skinnider, M. A., Dejong, C. A., Rees, P. N., Johnston, C. W., Li, H., Webster, A. L. H., Wyatt, M. A., & Magarvey, N. A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1012 · Cited by 268
Resistance-gene-directed discovery of a natural-product herbicide with a new mode of action
Yan, Y., Liu, Q., Zang, X., Yuan, S., Bat-Erdene, U., Nguyen, C., Gan, J., Zhou, J., Jacobsen, S. E., & Tang, Y. (2018) · Nature · doi:10.1038/s41586-018-0319-4 · Cited by 268
Ali, M. C., Chen, J., Zhang, H., Li, Z., Zhao, L., & Qiu, H. (2019) · Talanta · doi:10.1016/j.talanta.2019.05.012 · Cited by 264
Smith, A. J. T., Zhang, X., Leach, A. G., & Houk, K. N. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800498e · Cited by 193
Integrated Metabolomic–Genomic Workflows Accelerate Microbial Natural Product Discovery
Avalon, N. E., Murray, A. E., & Baker, B. J. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02245 · Cited by 47
Farooqi, A. A., Rakhmetova, V. S., Kapanova, G., Tashenova, G., Tulebayeva, A., Akhenbekova, A., Ibekenov, O., Turgambayeva, A., & Xu, B. (2023) · Molecules · doi:10.3390/molecules28052231 · Cited by 25
Muigg, P., Rosén, J., Bohlin, L., & Backlund, A. (2013) · Phytochemistry Reviews · doi:10.1007/s11101-012-9256-2 · Cited by 22
Metadata
- Authors
- Clardy, J., & Walsh, C.
- Venue
- Nature
- Published
- 2004-12
- Volume
- 432
- Issue
- 7019
- Pages
- 829-837
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2153478782
- Cited by
- 1,171
- References
- 75
- FWCI
- 22.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.